Clinical, functional and radiographic consequences of achieving stable low disease activity and remission with adalimumab plus methotrexate or methotrexate alone in early rheumatoid arthritis: 26-week results from the randomised, controlled OPTIMA study

Clinical, functional and radiographic consequences of achieving stable low disease activity and remission with adalimumab plus methotrexate or methotrexate alone in early rheumatoid arthritis: 26-week results from the randomised, controlled OPTIMA study

Bibliographic Details
Main Authors: Kavanaugh, Arthur, Fleischmann, Roy M, Emery, Paul, Kupper, Hartmut, Redden, Laura, Guerette, Benoit, Santra, Sourav, Smolen, Josef S
Format: Online
Language:English
Published: BMJ Group 2013
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3551224/

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3551224/

Similar Items